BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18508627)

  • 1. The tumor antigen EpCAM: tetraspanins and the tight junction protein claudin-7, new partners, new functions.
    Le Naour F; Zoller M
    Front Biosci; 2008 May; 13():5847-65. PubMed ID: 18508627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7.
    Ladwein M; Pape UF; Schmidt DS; Schnölzer M; Fiedler S; Langbein L; Franke WW; Moldenhauer G; Zöller M
    Exp Cell Res; 2005 Oct; 309(2):345-57. PubMed ID: 16054130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-7 regulates EpCAM-mediated functions in tumor progression.
    Nübel T; Preobraschenski J; Tuncay H; Weiss T; Kuhn S; Ladwein M; Langbein L; Zöller M
    Mol Cancer Res; 2009 Mar; 7(3):285-99. PubMed ID: 19276185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions.
    Wu CJ; Mannan P; Lu M; Udey MC
    J Biol Chem; 2013 Apr; 288(17):12253-68. PubMed ID: 23486470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression.
    Kuhn S; Koch M; Nübel T; Ladwein M; Antolovic D; Klingbeil P; Hildebrand D; Moldenhauer G; Langbein L; Franke WW; Weitz J; Zöller M
    Mol Cancer Res; 2007 Jun; 5(6):553-67. PubMed ID: 17579117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins.
    Lei Z; Maeda T; Tamura A; Nakamura T; Yamazaki Y; Shiratori H; Yashiro K; Tsukita S; Hamada H
    Dev Biol; 2012 Nov; 371(2):136-45. PubMed ID: 22819673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 variant isoforms associate with tetraspanins and EpCAM.
    Schmidt DS; Klingbeil P; Schnölzer M; Zöller M
    Exp Cell Res; 2004 Jul; 297(2):329-47. PubMed ID: 15212938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
    Patriarca C; Macchi RM; Marschner AK; Mellstedt H
    Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EpCAM: A new therapeutic target for an old cancer antigen.
    Armstrong A; Eck SL
    Cancer Biol Ther; 2003; 2(4):320-6. PubMed ID: 14508099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins.
    Wu CJ; Lu M; Feng X; Nakato G; Udey MC
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High interstitial fluid pressure is associated with low tumour penetration of diagnostic monoclonal antibodies applied for molecular imaging purposes.
    Heine M; Freund B; Nielsen P; Jung C; Reimer R; Hohenberg H; Zangemeister-Wittke U; Wester HJ; Lüers GH; Schumacher U
    PLoS One; 2012; 7(5):e36258. PubMed ID: 22590529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPCAM and TROP2 share a role in claudin stabilization and development of intestinal and extraintestinal epithelia in mice.
    Szabo R; Ward JM; Artunc F; Bugge TH
    Biol Open; 2022 Jul; 11(7):. PubMed ID: 35730316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
    Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of claudin-7 palmitoylation on membrane subdomain localization and metastasis-promoting activities.
    Heiler S; Mu W; Zöller M; Thuma F
    Cell Commun Signal; 2015 Jun; 13():29. PubMed ID: 26054340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
    Tauro BJ; Greening DW; Mathias RA; Mathivanan S; Ji H; Simpson RJ
    Mol Cell Proteomics; 2013 Mar; 12(3):587-98. PubMed ID: 23230278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM: structure and function in health and disease.
    Schnell U; Cirulli V; Giepmans BN
    Biochim Biophys Acta; 2013 Aug; 1828(8):1989-2001. PubMed ID: 23618806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EpCAM-claudin-tetraspanin-modulated ovarian cancer progression and drug resistance.
    Tavsan Z; Ayar Kayalı H
    Cell Adh Migr; 2020 Dec; 14(1):57-68. PubMed ID: 32091301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.
    Philip R; Heiler S; Mu W; Büchler MW; Zöller M; Thuma F
    Oncotarget; 2015 Feb; 6(4):2046-63. PubMed ID: 25514462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of the tetraspanin web of human colon cancer cells.
    Le Naour F; André M; Greco C; Billard M; Sordat B; Emile JF; Lanza F; Boucheix C; Rubinstein E
    Mol Cell Proteomics; 2006 May; 5(5):845-57. PubMed ID: 16467180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.